查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
傳染病體外診斷的市場規模、份額和趨勢分析報告：按產品（設備、試劑）、按應用（HPV、HIV）、按技術、按測試站點、按細分市場，2022-2030 年
市場調查報告書
商品編碼
1122233

傳染病體外診斷的市場規模、份額和趨勢分析報告：按產品（設備、試劑）、按應用（HPV、HIV）、按技術、按測試站點、按細分市場，2022-2030 年

Infectious Disease In Vitro Diagnostics Market Size, Share & Trends Analysis Report By Product (Instruments, Reagents), By Application (HPV, HIV), By Technology, By Test Location, And Segment Forecasts, 2022 - 2030
出版日期: | 出版商: Grand View Research | 英文 200 Pages | 商品交期: 2-10個工作天內

價格

傳染病體外診斷市場的增長和趨勢

根據 Grand View Research, Inc. 的最新報告，預計到 2030 年，全球傳染病體外診斷市場規模將達到 566 億美元，2022 年至 2030 年的複合年增長率為 -7.4%。結核病和 COVID-19 等傳染病的日益流行以及技術進步預計將推動未來幾年的產品需求。耐多藥感染的增加正在加強對傳染病的早期診斷。例如，MDR 感染在 ICU 患者中非常常見，而根據 2021 年《Microbial Drug Resistance Journal》，重症 SARS-CoV-2 患者的 MDR 感染患病率在 14% 到 50% 之間。

傳染病的診斷前診斷和抗生素治療的延誤進一步加劇了耐藥細菌的傳播，為行業發展創造了有利可圖的機會。該行業已推出大量產品以滿足消費者的需求。例如，2022 年 5 月，BD 在美國宣布了一個傳染病自動診斷平台。該系統可裝載 1700 個樣品，並且無需進行樣品分類，從而減少錯誤。各種競爭對手提供的產品具有戰略性定價，以增加競爭對手之間的競爭。

然而，POC測試和實驗室測試有著不同的敏感性和認知，當消費者不得不在兩者之間做出選擇時，購買行為的複雜性就變得顯而易見。該行業為寡頭壟斷，Hoffmann-La Roche Ltd.、Alere、bioMerieux 和 BD 等公司共同持有大部分市場份額。全球行業對價格敏感，在生產具有成本效益和高效的產品方面造成參與者之間的激烈競爭。由於預計將推出新型生物標誌物試劑盒，預計競爭對手之間的競爭將在預測期內加劇。競爭對手正在採取重要策略，例如產品發布和教育活動，以獲取更高的市場份額。

傳染病體外診斷市場報告亮點

由於在測試中大量使用，試劑產品部門在 2021 年佔最大的收入份額。

分子診斷領域在 2021 年佔最大份額，原因是該領域的產品發布數量增加，並且由於高精度而採用率增加。

按應用劃分，COVID-19 細分市場在 2021 年主導了行業，在檢測方面的支出很高，以遏制病毒的傳播

與 PoC 和家庭測試相比，中心實驗室部分更可靠，因為基於實驗室的測試具有更高的準確性，並且這些測試與其他兩個部分相比具有競爭力。，在 2021 年佔最高收入份額

由於良好的監管框架、專注於預防和早期檢測以及該地區對新型診斷方法的高度採用，北美在 2021 年主導了全球行業

目錄

第一章 調查方法和範圍

  • 市場細分和範圍
    • 產品
    • 技術
    • 應用
    • 測試地點
    • 區域範圍
  • 調查方法
  • 信息採購
    • 購買的數據庫
    • GVR 內部數據庫
    • 次要信息
    • 初步調查
    • 第一次調查的內容
      • 北美初級面試數據
      • 來自歐洲的初步訪談數據
      • 亞太地區主要訪談數據
      • 中東和非洲的主要採訪數據
  • 信息或數據分析
    • 數據分析模型
  • 市場製定和驗證
  • 型號詳情
    • 商品流向分析（模型一）
      • 方法一：商品流動方法
  • 二級信息列表
  • 縮略語表
  • 目的

第二章執行摘要

  • 市場展望
  • 細分洞察
  • 競爭考慮

3. 體外診斷市場的變量、趨勢和範圍

  • 市場系列展望
    • 母公司的市場前景
  • 繪製滲透率和增長前景
  • 用戶視角分析
    • 消費者行為分析
    • 市場影響者分析
    • 關鍵最終用戶列表
  • 監管框架
  • 市場動態
    • 市場驅動力分析
      • 老年人口不斷增長
      • 技術進步
      • 對 PoC 設施的高需求
      • 傳染病的傳播
      • 研發活動的外部資金
    • 市場約束分析
      • IVD 測試的高價格
    • 行業挑戰
      • 存在模糊的監管框架
  • 傳染病體外診斷市場分析工具
    • 行業分析——波特五力
    • 杵分析
    • 重大交易和戰略聯盟分析
      • 新產品發布
      • 併購
      • 擴張
      • 合夥
      • 營銷和推廣
    • 市場進入策略

第 4 章傳染病體外診斷市場細分分析，按產品，2018-2030 年（百萬美元）

  • 定義和範圍
  • 2021 年和 2030 年產品類型市場份額分析
  • 細分儀表板
  • 2018-2030年按產品分列的全球體外診斷市場
  • 市場規模和預測，趨勢分析，2018-2030
    • 機器
    • 試劑
    • 軟件

第 5 章傳染病體外診斷市場細分分析，按技術，2018-2030 年（百萬美元）

  • 定義和範圍
  • 2021 年和 2030 年技術類型市場份額分析
  • 細分儀表板
  • 2018-2030 年按技術分列的全球傳染病體外診斷市場
  • 市場規模和預測，趨勢分析，2018-2030
    • 免疫測定
    • 分子診斷
      • 聚合□鍊式反應 (PCR)
      • 原位雜交
      • 等溫核酸擴增技術 (INAAT)
      • 芯片和微陣列
      • 測序和NGS
      • 轉錄介導的擴增
      • 其他
    • 微生物學
    • 其他

6. 按應用分列的傳染病體外診斷市場細分分析，2018-2030 年（百萬美元）

  • 定義和範圍
  • 2021 年和 2030 年應用類型市場份額分析
  • 細分儀表板
  • 2018-2030 年按應用分列的全球傳染病體外診斷市場
  • 市場規模和預測，趨勢分析，2018-2030
    • 耐甲氧西林金黃色葡萄球菌
    • 鏈球菌
    • 艱難梭菌
    • 耐萬古黴素腸球菌（VRE）
    • 耐碳青黴烯類腸道細菌試驗（CRE）
    • 呼吸道病毒
    • 念珠菌
    • 結核病 (TB) 和耐藥結核病
    • 胃腸道 (GI) 小組測試
    • 衣原體
    • 淋病
    • 人乳頭瘤病毒 (HPV)
    • 人類免疫缺陷病毒 (HIV)
    • 丙型肝炎
    • 乙型肝炎
    • 新冠肺炎）
    • 其他

7. 傳染病體外診斷市場細分分析，按測試地點，2018-2030 年（百萬美元）

  • 定義和範圍
  • 2021 年和 2030 年測試位置類型的市場份額分析
  • 細分儀表板
  • 全球傳染病體外診斷市場，按測試地點，2018-2030
  • 市場規模和預測，趨勢分析，2018-2030
    • 注意事項
    • 中央研究院
    • 其他

8. 2018-2030 年按地區分列的傳染病體外診斷市場細分分析（百萬美元）

  • 定義和範圍
  • 2021 年和 2030 年區域市場份額分析
  • 區域市場儀表板
  • 區域市場快照
  • 2021 年區域市場份額和主要參與者
    • 北美
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲
  • SWOT分析
    • 北美
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲
  • 2021-2030 年市場規模、預測、收入、趨勢分析
    • 北美
      • 美國
      • 加拿大
    • 歐洲
      • 英國
      • 德國
      • 西班牙
      • 法國
      • 意大利
    • 亞太地區
      • 日本
      • 中國
      • 印度
      • 韓國
      • 澳大利亞
    • 拉丁美洲
      • 巴西
      • 墨西哥
      • 阿根廷
    • 多邊環境協定
      • 南非
      • 沙特阿拉伯
      • 阿拉伯聯合酋長國

第 9 章 競爭格局

  • 主要市場參與者的最新發展和影響分析
    • 安索夫矩陣
    • 熱圖分析
  • 公司分類
    • 創新者
    • 市場領導者
  • 供應商情況
    • 主要經銷商及渠道合作夥伴名單
    • 主要客戶
    • 2021 年主要參與者的市場份額分析
  • 上市公司
    • 公司市場分析
    • 2021年各地區公司市場份額
    • 競爭儀錶盤分析
      • 市場差異化因素
  • 民營企業
    • 主要初創企業名單
  • 公司簡介
    • BD
      • 公司簡介
      • 財務績效
      • 產品基準
      • 戰略舉措
    • bioMerieux SA
      • 公司簡介
      • 財務績效
      • 產品基準
      • 戰略舉措
    • Abbott
      • 公司簡介
      • 財務績效
      • 產品基準
      • 戰略舉措
    • Quidel Corporation
      • 公司簡介
      • 財務績效
      • 產品基準
      • 戰略舉措
    • OraSure Technologies, Inc.
      • 公司簡介
      • 財務績效
      • 產品基準
      • 戰略舉措
    • Hologic Inc. (Gen-Probe)
      • 公司簡介
      • 財務績效
      • 產品基準
      • 戰略舉措
    • Cepheid（Danaher）
      • 公司簡介
      • 財務績效
      • 產品基準
      • 戰略舉措
    • QIAGEN
      • 公司簡介
      • 財務績效
      • 產品基準
      • 戰略舉措
    • F. Hoffmann-La Roche Ltd.
      • 公司簡介
      • 財務績效
      • 產品基準
      • 戰略舉措
    • Siemens Healthcare GmbH
      • 公司簡介
      • 財務績效
      • 產品基準
      • 戰略舉措
    • Bio-Rad Laboratories, Inc.
      • 公司簡介
      • 財務績效
      • 產品基準
      • 戰略舉措
Product Code: 978-1-68038-716-2

Infectious Disease In Vitro Diagnostics Market Growth & Trends:

The global infectious disease in vitro diagnostics market size is expected to reach USD 56.60 billion by 2030, registering a CAGR of -7.4% from 2022 to 2030, according to a new report by Grand View Research, Inc. The rising prevalence of infectious diseases, such as tuberculosis & COVID-19, and technological advancements are projected to drive the product demand in the coming years. The rising prevalence of multi-drug resistant infections is enhancing the early diagnosis of infectious diseases. For instance, MDR infections are highly common in ICU patients, as per the Microbial Drug Resistance Journal in 2021, the prevalence of MDR infections in critically ill SARS-CoV-2 patients ranged between14% and 50%.

The delay in diagnosis and treatment with antibiotics before infection diagnosis is further escalating the prevalence of drug resistant-bacteria, creating a lucrative opportunity for industry growth. The industry is witnessing a significant number of product launches to meet the demands of consumers. For instance, in May 2022, BD introduced its automated diagnostic platform for infectious diseases in the U.S. The system allows the loading of 1700 specimens and the need for specimen sorting is also eliminated, thereby, reducing errors. Products offered by various competitors have been strategically priced to increase competitive rivalry.

However, complexity in buying behavior increases prominently when consumers have to choose between PoC and lab-based tests owing to differences in sensitivity and beliefs. The industry is oligopolistic with companies, such as Hoffmann-La Roche Ltd., Alere, bioMerieux, and BD, holding the majority of the share collectively. The global industry is price-sensitive, creating rigorous competition among players in terms of manufacturing cost-effective and efficient products. Competitive rivalry is estimated to increase during the forecast period owing to the expected launch of novel biomarker kits. Competitors are adopting key strategies, such as product launches and organizing awareness programs, to gain higher market shares.

Infectious Disease In Vitro Diagnostics Market Report Highlights:

  • The reagents product segment held the largest revenue share in 2021 owing to its high volume usage in testing
  • The molecular diagnostics segment held the largest share in 2021 owing to an increased number of product launches in the segment and increased adoption due to its high accuracy
  • By application, the COVID-19 segment dominated the industry in 2021 due to the high expenditure on testing, to reduce the spread of the virus
  • The central laboratories segment held the highest revenue share in 2021 due to the higher accuracy of laboratory-based tests, which makes them more reliable as compared to PoC and home tests, giving these tests a competitive edge over the other two segments
  • North America dominated the global industry in 2021 due to its favorable regulatory framework, focus on preventive & early testing, and the higher adoption rate of novel diagnostics in this region

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market Segmentation & Scope
    • 1.1.1 Product
    • 1.1.2 Technology
    • 1.1.3 Application
    • 1.1.4 Test Location
    • 1.1.5 Regional Scope
    • 1.1.6 Estimates and forecast timeline
  • 1.2 Research Methodology
  • 1.3 Information procurement
    • 1.3.1 Purchased database
    • 1.3.2 GVR's internal database
    • 1.3.3 Secondary sources
    • 1.3.4 Primary research
    • 1.3.5 Details of primary research
      • 1.3.5.1 Data for primary interviews in North America
      • 1.3.5.2 Data for primary interviews in Europe
      • 1.3.5.3 Data for primary interviews in Asia Pacific
      • 1.3.5.4 Data for primary interviews in Middle East and Africa
  • 1.4 Information or Data Analysis
    • 1.4.1 Data analysis models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Commodity Flow Analysis (Model 1)
      • 1.6.1.1 Approach 1: Commodity Flow Approach
  • 1.7 List of Secondary Sources
  • 1.8 List of Abbreviations
  • 1.9 Objectives
    • 1.9.1 Objective 1
    • 1.9.2 Objective 2
    • 1.9.3 Objective 3
    • 1.9.4 Objective 4

Chapter 2 Executive Summary

  • 2.1 Market Outlook
  • 2.2 Segment Insights
  • 2.3 Competitive Insights

Chapter 3 IVD Infectious Disease Market Variables, Trends & Scope

  • 3.1 Market Lineage Outlook
    • 3.1.1 Parent market outlook
  • 3.2 Penetration and Growth Prospect Mapping
  • 3.3 User Perspective Analysis
    • 3.3.1 Consumer behavior analysis
    • 3.3.2 Market influencer analysis
    • 3.3.3 List of key end users
  • 3.4 Regulatory Framework
  • 3.5 Market Dynamics
    • 3.5.1 Market driver analysis
      • 3.5.1.1 Growing geriatric population
      • 3.5.1.2 Technological advancements
      • 3.5.1.3 High demand for PoC facilities
      • 3.5.1.4 Increasing prevalence of infectious diseases
      • 3.5.1.5 External funding for R&D activities
    • 3.5.2 Market restraint analysis
      • 3.5.2.1 High prices of IVD tests
    • 3.5.3 Industry challenges
      • 3.5.3.1 Presence of ambiguous regulatory framework
  • 3.6 IVD Infectious Disease Market Analysis Tools
    • 3.6.1 Industry Analysis - Porter's Five Forces
    • 3.6.2 PESTLE Analysis
    • 3.6.3 Major deals and strategic alliances analysis
      • 3.6.3.1 New product launch
      • 3.6.3.2 Mergers and acquisitions
      • 3.6.3.3 Expansion
      • 3.6.3.4 Partnerships
      • 3.6.3.5 Marketing & promotions
    • 3.6.4 Market entry strategies

Chapter 4 IVD Infectious Diseases Market - Segment Analysis, By Product, 2018 - 2030 (USD Million)

  • 4.1 Definition and Scope
  • 4.2 Product Type Market Share Analysis, 2021 & 2030
  • 4.3 Segment Dashboard
  • 4.4 Global IVD Infectious Diseases Market, by Product, 2018 to 2030
  • 4.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
    • 4.5.1 Instruments
      • 4.5.1.1 Instruments market estimates and forecast, 2018 - 2030 (USD Million)
    • 4.5.2 Reagents
      • 4.5.2.1 Reagents market estimates and forecast, 2018 - 2030 (USD Million)
    • 4.5.3 Software
      • 4.5.3.1 Software market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 5 IVD Infectious Diseases Market - Segment Analysis, By Technology, 2018 - 2030 (USD Million)

  • 5.1 Definition and Scope
  • 5.2 Technology Type Market Share Analysis, 2021 & 2030
  • 5.3 Segment Dashboard
  • 5.4 Global IVD Infectious Diseases Market, by Technology, 2018 to 2030
  • 5.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
    • 5.5.1 Immunoassay
      • 5.5.1.1 Immunoassay market estimates and forecast, 2018 - 2030 (USD Million)
    • 5.5.2 Molecular Diagnostics
      • 5.5.2.1 Molecular diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
      • 5.5.2.3 Polymerase Chain Reaction (PCR)
      • 5.5.2.3.1 Polymerase Chain Reaction (PCR) market estimates and forecast, 2018 - 2030 (USD Million)
      • 5.5.2.4 In Situ Hybridization
      • 5.5.2.4.1 In situ hybridization market estimates and forecast, 2018 - 2030 (USD Million)
      • 5.5.2.5 Isothermal Nucleic Acid Amplification Technology (INAAT)
      • 5.5.2.5.1 Isothermal Nucleic Acid Amplification Technology (INAAT) market estimates and forecast, 2018 - 2030 (USD Million)
      • 5.5.2.6 Chips and Microarrays
      • 5.5.2.6.1 Chips and microarrays market estimates and forecast, 2018 - 2030 (USD Million)
      • 5.5.2.7 Sequencing & NGS
      • 5.5.2.7.1 Sequencing & NGS market estimates and forecast, 2018 - 2030 (USD Million)
      • 5.5.2.8 Transcription Mediated Amplification
      • 5.5.2.8.1 Transcription mediated amplification market estimates and forecast, 2018 - 2030 (USD Million)
      • 5.5.2.9 Others
      • 5.5.2.9.1 Others market estimates and forecast, 2018 - 2030 (USD Million)
    • 5.5.3 Microbiology
      • 5.5.3.1 Microbiology market estimates and forecast, 2018 - 2030 (USD Million)
    • 5.5.4 Others
      • 5.5.4.1 Others market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 6 IVD Infectious Diseases Market - Segment Analysis, By Application, 2018 - 2030 (USD Million)

  • 6.1 Definition and Scope
  • 6.2 Application Type Market Share Analysis, 2021 & 2030
  • 6.3 Segment Dashboard
  • 6.4 Global IVD Infectious Diseases Market, by Application, 2018 to 2030
  • 6.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
    • 6.5.1 MRSA
      • 6.5.1.1 MRSA market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.5.2 Streptococcus
      • 6.5.2.1 Streptococcus market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.5.3 Clostridium Difficile
      • 6.5.3.1 Clostridium difficile market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.5.4 Vancomycin-resistant Enterococci (VRE)
      • 6.5.4.1 VRE market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.5.5 Carbapenem-resistant Enterobacterial Testing (CRE)
      • 6.5.5.1 CRE market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.5.6 Respiratory Virus
      • 6.5.6.1 Respiratory virus market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.5.7 Candida
      • 6.5.7.1 Candida market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.5.8 Tuberculosis (TB) & Drug-resistant TB
      • 6.5.8.1 TB & drug-resistant TB market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.5.9 Gastrointestinal (GI) Panel Testing
      • 6.5.9.1 GI panel testing market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.5.10 Chlamydia
      • 6.5.10.1 Chlamydia market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.5.11 Gonorrhea
      • 6.5.11.1 Gonorrhea market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.5.12 Human papillomavirus (HPV)
      • 6.5.12.1 HPV market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.5.13 Human immunodeficiency virus (HIV)
      • 6.5.13.1 HIV market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.5.14 Hepatitis C
      • 6.5.14.1 Hepatitis C market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.5.15 Hepatitis B
      • 6.5.15.1 Hepatitis B market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.5.16 COVID-19
      • 6.5.16.1 COVID-19 market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.5.17 Others
      • 6.5.17.1 Others market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 7 IVD Infectious Diseases Market - Segment Analysis, By Test Location, 2018 - 2030 (USD Million)

  • 7.1 Definition and Scope
  • 7.2 Test Location Type Market Share Analysis, 2021 & 2030
  • 7.3 Segment Dashboard
  • 7.4 Global IVD Infectious Diseases Market, by Test Location, 2018 to 2030
  • 7.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
    • 7.5.1 Point of Care
      • 7.5.1.1 Point of Care market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.5.2 Central Laboratories
      • 7.5.2.1 Central laboratories market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.5.3 Others
      • 7.5.3.1 Others market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 8 IVD Infectious Diseases Market - Segment Analysis, By Region, 2018 - 2030 (USD Million)

  • 8.1 Definition & Scope
  • 8.2 Regional Market Share Analysis, 2021 & 2030
  • 8.3 Regional Market Dashboard
  • 8.4 Regional Market Snapshot
  • 8.5 Regional Market Share and Leading Players, 2021
    • 8.5.1 North America
    • 8.5.2 Europe
    • 8.5.3 Asia Pacific
    • 8.5.4 Latin America
    • 8.5.5 Middle East and Africa
  • 8.6 SWOT Analysis
    • 8.6.1 North America
    • 8.6.2 Europe
    • 8.6.3 Asia Pacific
    • 8.6.4 Latin America
    • 8.6.5 Middle East and Africa
  • 8.7 Market Size, & Forecasts, Revenue and Trend Analysis, 2021 to 2030
    • 8.7.1 North America
      • 8.7.1.1 North America market estimates and forecast, 2018 - 2030 (USD Million)
      • 8.7.1.2 U.S.
      • 8.7.1.2.1 U.S. IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
      • 8.7.1.3 Canada
      • 8.7.1.3.1 Canada IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.7.2 Europe
      • 8.7.2.1 Europe market estimates and forecast, 2018 - 2030 (USD Million)
      • 8.7.2.2 U.K.
      • 8.7.2.2.1 U.K. IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
      • 8.7.2.3 Germany
      • 8.7.2.3.1 Germany IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
      • 8.7.2.4 Spain
      • 8.7.2.4.1 Spain IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
      • 8.7.2.5 France
      • 8.7.2.5.1 France IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
      • 8.7.2.6 Italy
      • 8.7.2.6.1 Italy IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.7.3 Asia Pacific
      • 8.7.3.1 Asia Pacific market estimates and forecast estimates and forecast, 2018 - 2030 (USD Million)
      • 8.7.3.2 Japan
      • 8.7.3.2.1 Japan IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
      • 8.7.3.3 China
      • 8.7.3.3.1 China IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
      • 8.7.3.4 India
      • 8.7.3.4.1 India IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
      • 8.7.3.5 South Korea
      • 8.7.3.5.1 South Korea IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
      • 8.7.3.6 Australia
      • 8.7.3.6.1 Australia IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.7.4 Latin America
      • 8.7.4.1 Latin America market estimates and forecast estimates and forecast, 2018 - 2030 (USD Million)
      • 8.7.4.2 Brazil
      • 8.7.4.2.1 Brazil IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
      • 8.7.4.3 Mexico
      • 8.7.4.3.1 Mexico IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
      • 8.7.4.4 Argentina
      • 8.7.4.4.1 Argentina IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.7.5 MEA
      • 8.7.5.1 MEA market estimates and forecast estimates and forecast, 2018 - 2030 (USD Million)
      • 8.7.5.2 South Africa
      • 8.7.5.2.1 South Africa IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
      • 8.7.5.3 Saudi Arabia
      • 8.7.5.3.1 Saudi Arabia IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
      • 8.7.5.4 UAE
      • 8.7.5.4.1 UAE IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 9 Competitive Landscape

  • 9.1 Recent Developments & Impact Analysis, by Key Market Participants
    • 9.1.1 Ansoff matrix
    • 9.1.2 Heat map analysis
  • 9.2 Company Categorization
    • 9.2.1 Innovators
    • 9.2.2 Market Leaders
  • 9.3 Vendor Landscape
    • 9.3.1 List of key distributors and channel partners
    • 9.3.2 Key customers
    • 9.3.3 Key company market share analysis, 2021
  • 9.4 Public Companies
    • 9.4.1 Company market position analysis
    • 9.4.2 Company market share, by region, 2021
    • 9.4.3 Competitive dashboard analysis
      • 9.4.3.1 Market Differentiators
  • 9.5 Private Companies
    • 9.5.1 List of key emerging companies
  • 9.6 Company Profiles
    • 9.6.1 BD
      • 9.6.1.1 Company overview
      • 9.6.1.2 Financial performance
      • 9.6.1.3 Product benchmarking
      • 9.6.1.4 Strategic initiatives
    • 9.6.2 bioMerieux SA
      • 9.6.2.1 Company overview
      • 9.6.2.2 Financial performance
      • 9.6.2.3 Product benchmarking
      • 9.6.2.4 Strategic initiatives
    • 9.6.3 Abbott
      • 9.6.3.1 Company overview
      • 9.6.3.2 Financial performance
      • 9.6.3.3 Product benchmarking
      • 9.6.3.4 Strategic initiatives
    • 9.6.4 Quidel Corporation
      • 9.6.4.1 Company overview
      • 9.6.4.2 Financial performance
      • 9.6.4.3 Product benchmarking
      • 9.6.4.4 Strategic initiatives
    • 9.6.5 OraSure Technologies, Inc
      • 9.6.5.1 Company overview
      • 9.6.5.2 Financial performance
      • 9.6.5.3 Product benchmarking
      • 9.6.5.4 Strategic initiatives
    • 9.6.6 Hologic Inc. (Gen-Probe)
      • 9.6.6.1 Company overview
      • 9.6.6.2 Financial performance
      • 9.6.6.3 Product benchmarking
      • 9.6.6.4 Strategic initiatives
    • 9.6.7 Cepheid (Danaher)
      • 9.6.7.1 Company overview
      • 9.6.7.2 Financial performance
      • 9.6.7.3 Product benchmarking
      • 9.6.7.4 Strategic initiatives
    • 9.6.8 QIAGEN
      • 9.6.8.1 Company overview
      • 9.6.8.2 Financial performance
      • 9.6.8.3 Product benchmarking
      • 9.6.8.4 Strategic initiatives
    • 9.6.9 F. Hoffmann-La Roche Ltd.
      • 9.6.9.1 Company overview
      • 9.6.9.2 Financial performance
      • 9.6.9.3 Product benchmarking
      • 9.6.9.4 Strategic initiatives
    • 9.6.10 Siemens Healthcare GmbH
      • 9.6.10.1 Company overview
      • 9.6.10.2 Financial performance
      • 9.6.10.3 Product benchmarking
      • 9.6.10.4 Strategic initiatives
    • 9.6.11 Bio-Rad Laboratories, Inc.
      • 9.6.11.1 Company overview
      • 9.6.11.2 Financial performance
      • 9.6.11.3 Product benchmarking
      • 9.6.11.4 Strategic initiatives

List of Tables

  • TABLE 1 List of Secondary Sources
  • TABLE 2 List of Abbreviations
  • TABLE 3 Regulatory Framework
  • TABLE 4 Global IVD Infectious Diseases Market, By Region, 2018 - 2030 (USD Million)
  • TABLE 5 Global IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Million)
  • TABLE 6 Global IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Million)
  • TABLE 7 Global IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Million)
  • TABLE 8 Global IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Million)
  • TABLE 9 North America IVD Infectious Diseases Market, By Country, 2018 - 2030 (USD Million)
  • TABLE 10 North America IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Million)
  • TABLE 11 North America IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Million)
  • TABLE 12 North America IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Million)
  • TABLE 13 North America IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Million)
  • TABLE 14 U.S. IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Million)
  • TABLE 15 U.S. IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Million)
  • TABLE 16 U.S. IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Million)
  • TABLE 17 U.S. IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Million)
  • TABLE 18 Canada IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Million)
  • TABLE 19 Canada IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Million)
  • TABLE 20 Canada IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Million)
  • TABLE 21 Canada IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Million)
  • TABLE 22 Europe IVD Infectious Diseases Market, By Country, 2018 - 2030 (USD Million)
  • TABLE 23 Europe IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Million)
  • TABLE 24 Europe IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Million)
  • TABLE 25 Europe IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Million)
  • TABLE 26 Europe IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Million)
  • TABLE 27 U.K. IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Million)
  • TABLE 28 U.K. IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Million)
  • TABLE 29 U.K. IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Million)
  • TABLE 30 U.K. IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Million)
  • TABLE 31 Germany IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Million)
  • TABLE 32 Germany America IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Million)
  • TABLE 33 Germany America IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Million)
  • TABLE 34 Germany America IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Million)
  • TABLE 35 France IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Million)
  • TABLE 36 France IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Million)
  • TABLE 37 France IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Million)
  • TABLE 38 France IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Million)
  • TABLE 39 Spain IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Million)
  • TABLE 40 Spain IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Million)
  • TABLE 41 Spain IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Million)
  • TABLE 42 Spain IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Million)
  • TABLE 43 Italy IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Million)
  • TABLE 44 Italy IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Million)
  • TABLE 45 Italy IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Million)
  • TABLE 46 Italy IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Million)
  • TABLE 47 Asia Pacific IVD Infectious Diseases Market, By Country, 2018 - 2030 (USD Million)
  • TABLE 48 Asia Pacific IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Million)
  • TABLE 49 Asia Pacific IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Million)
  • TABLE 50 Asia Pacific IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Million)
  • TABLE 51 Asia Pacific IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Million)
  • TABLE 52 China IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Million)
  • TABLE 53 China IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Million)
  • TABLE 54 China IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Million)
  • TABLE 55 China IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Million)
  • TABLE 56 Japan IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Million)
  • TABLE 57 Japan IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Million)
  • TABLE 58 Japan IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Million)
  • TABLE 59 Japan IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Million)
  • TABLE 60 India IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Million)
  • TABLE 61 India IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Million)
  • TABLE 62 India IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Million)
  • TABLE 63 India IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Million)
  • TABLE 64 South Korea IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Million)
  • TABLE 65 South Korea IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Million)
  • TABLE 66 South Korea IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Million)
  • TABLE 67 South Korea IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Million)
  • TABLE 68 Singapore IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Million)
  • TABLE 69 Singapore IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Million)
  • TABLE 70 Singapore IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Million)
  • TABLE 71 Singapore IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Million)
  • TABLE 72 Australia IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Million)
  • TABLE 73 Australia IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Million)
  • TABLE 74 Australia IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Million)
  • TABLE 75 Australia IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Million)
  • TABLE 76 Latin America IVD Infectious Diseases Market, By Country, 2018 - 2030 (USD Million)
  • TABLE 77 Latin America IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Million)
  • TABLE 78 Latin America IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Million)
  • TABLE 79 Latin America IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Million)
  • TABLE 80 Latin America IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Million)
  • TABLE 81 Brazil IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Million)
  • TABLE 82 Brazil IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Million)
  • TABLE 83 Brazil IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Million)
  • TABLE 84 Brazil IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Million)
  • TABLE 85 Mexico IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Million)
  • TABLE 86 Mexico IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Million)
  • TABLE 87 Mexico IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Million)
  • TABLE 88 Mexico IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Million)
  • TABLE 89 Argentina IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Million)
  • TABLE 90 Argentina IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Million)
  • TABLE 91 Argentina IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Million)
  • TABLE 92 Argentina IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Million)
  • TABLE 93 MEA IVD Infectious Diseases Market, By Country, 2018 - 2030 (USD Million)
  • TABLE 94 MEA IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Million)
  • TABLE 95 MEA IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Million)
  • TABLE 96 MEA IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Million)
  • TABLE 97 MEA IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Million)
  • TABLE 98 South Africa IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Million)
  • TABLE 99 South Africa IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Million)
  • TABLE 100 South Africa IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Million)
  • TABLE 101 South Africa IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Million)
  • TABLE 102 UAE IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Million)
  • TABLE 103 UAE IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Million)
  • TABLE 104 UAE IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Million)
  • TABLE 105 UAE IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Million)
  • TABLE 106 Saudi Arabia IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Million)
  • TABLE 107 Saudi Arabia IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Million)
  • TABLE 108 Saudi Arabia IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Million)
  • TABLE 109 Saudi Arabia IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Million)

List of Figures

  • FIG. 1 IVD infectious diseases market segmentation
  • FIG. 2 Market research process
  • FIG. 3 Information procurement
  • FIG. 4 Primary research pattern
  • FIG. 5 Primary interviews in North America
  • FIG. 6 Primary interviews in Europe
  • FIG. 7 Primary interviews in Asia Pacific
  • FIG. 8 Primary interviews in Middle East and Africa
  • FIG. 9 Market research approaches
  • FIG. 10 Value-chain-based sizing & forecasting
  • FIG. 11 QFD modeling for market share assessment
  • FIG. 12 Market formulation & validation
  • FIG. 13 IVD infectious disease market snapshot
  • FIG. 14 Segment Insights
  • FIG. 15 Strategy framework
  • FIG. 16 Penetration & growth prospect mapping
  • FIG. 17 Consumer behavior analysis
  • FIG. 18 Factors influencing North America IVD infectious diseases market (%)
  • FIG. 19 Factors influencing Europe IVD infectious diseases market (%)
  • FIG. 20 Factors influencing Asia Pacific IVD infectious diseases market (%)
  • FIG. 21 Factors influencing Latin America IVD infectious diseases market (%)
  • FIG. 22 Factors influencing Middle East and Africa IVD infectious diseases market (%)
  • FIG. 23 Market driver relevance analysis (Current & future impact)
  • FIG. 24 Global population growth, by age group, 2012 - 2021 (Million)
  • FIG. 25 Global percentage of the population, by age group, 2000 and 2050
  • FIG. 26 General trend of CLIA-waived tests
  • FIG. 27 Market restraint relevance analysis (Current & future impact)
  • FIG. 28 Porter's five forces analysis
  • FIG. 29 PESTLE analysis
  • FIG. 30 Strategy mapping
  • FIG. 31 IVD infectious diseases market: Product movement analysis
  • FIG. 32 Product segment dashboard
  • FIG. 33 IVD infectious diseases market product outlook: Key takeaways
  • FIG. 34 Instruments market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 35 Reagents market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 36 Software market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 37 IVD infectious diseases market: Technology movement analysis
  • FIG. 38 Technology segment dashboard
  • FIG. 39 IVD infectious diseases market technology outlook: Key takeaways
  • FIG. 40 Immunoassay market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 41 Molecular diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 42 Polymerase Chain Reaction (PCR) market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 43 In Situ Hybridization market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 44 Isothermal Nucleic Acid Amplification Technology (INAAT) market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 45 Chips and microarrays market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 46 Sequencing & NGS market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 47 Transcription Mediated Amplification market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 48 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 49 Microbiology market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 50 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 51 IVD infectious diseases market: Technology movement analysis
  • FIG. 52 Application segment dashboard
  • FIG. 53 IVD infectious diseases market technology outlook: Key takeaways
  • FIG. 54 MRSA market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 55 Streptococcus market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 56 Clostridium difficile market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 57 VRE market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 58 CRE market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 59 Respiratory virus market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 60 Candida market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 61 TB & drug-resistant TB market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 62 GI panel testing market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 63 Chlamydia market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 64 Gonorrhea market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 65 HPV market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 66 HIV market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 67 Hepatitis C market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 68 Hepatitis B market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 69 COVID-19 market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 70 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 71 IVD infectious diseases market: Test location movement analysis
  • FIG. 72 Test location segment dashboard
  • FIG. 73 IVD infectious diseases market test location outlook: Key takeaways
  • FIG. 74 Point of Care market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 75 Central laboratories market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 76 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 77 Regional outlook, 2021 & 2030
  • FIG. 78 Regional market dashboard
  • FIG. 79 Regional marketplace: Key takeaways
  • FIG. 80 North America market share and leading players, 2021
  • FIG. 81 Europe market share and leading players, 2021
  • FIG. 82 Asia Pacific market share and leading players, 2021
  • FIG. 83 Latin America market share and leading players, 2021
  • FIG. 84 Middle East and Africa market share and leading players, 2021
  • FIG. 85 North America, SWOT
  • FIG. 86 Europe, SWOT
  • FIG. 87 Asia Pacific, SWOT
  • FIG. 88 Latin America, SWOT
  • FIG. 89 Middle East and Africa, SWOT
  • FIG. 90 North America
  • FIG. 91 North America IVD infectious diseases market, 2018 - 2030 (USD Million)
  • FIG. 92 U.S.
  • FIG. 93 U.S. IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 94 Canada
  • FIG. 95 Canada IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 96 Europe
  • FIG. 97 Europe IVD infectious diseases market, 2018 - 2030 (USD Million)
  • FIG. 98 U.K.
  • FIG. 99 U.K. IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 100 Germany
  • FIG. 101 Germany IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 102 Spain
  • FIG. 103 Spain IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 104 France
  • FIG. 105 France IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 106 Italy
  • FIG. 107 Italy IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 108 Asia Pacific
  • FIG. 109 Asia Pacific IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 110 Japan
  • FIG. 111 Japan IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 112 China
  • FIG. 113 China IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 114 India
  • FIG. 115 India IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 116 South Korea
  • FIG. 117 South Korea IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 118 Australia
  • FIG. 119 Australia IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 120 Latin America
  • FIG. 121 Latin America IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 122 Brazil
  • FIG. 123 Brazil IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 124 Mexico
  • FIG. 125 Mexico IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 126 Argentina
  • FIG. 127 Argentina IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 128 MEA
  • FIG. 129 MEA IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 130 South Africa
  • FIG. 131 South Africa IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 132 Saudi Arabia
  • FIG. 133 Saudi Arabia IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 134 UAE
  • FIG. 135 UAE IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 136 Ansoff Matrix
  • FIG. 137 Heat map analysis
  • FIG. 138 Company market share analysis
  • FIG. 139 Company market position analysis
  • FIG. 140 Company market share, by region, 2021
  • FIG. 141 Market differentiators